Clinical Perspectives in the Evolving Treatment of Advanced Endometrial Carcinoma: Highlights from SGO 2023

David O’Malley, MD, provides a comprehensive overview of endometrial carcinoma and treatment options for patients in this setting.

David O’Malley, MD, an expert gynecologic oncologist, details molecular profiling and risk stratification for patients with advanced endometrial carcinoma.

A brief review of the current treatment armamentarium for advanced endometrial carcinoma.

An expert gynecologic oncologist reviews recent updates presented at SGO 2023 from the KEYNOTE-775 trial for advanced endometrial carcinoma.

David O’Malley, MD, details patient tolerance and associated adverse events with lenvatinib plus pembrolizumab for advanced endometrial carcinoma.

David O’Malley, MD, an expert on advanced endometrial carcinoma, shares additional highlights presented at SGO 2023.

Closing the discussion on advanced endometrial carcinoma, Dr David O’Malley shares his perspective on the future treatment landscape.